About Ocuphire Pharma, Inc. 
Ocuphire Pharma, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 4 Schemes (4.49%)
Foreign Institutions
Held by 13 Foreign Institutions (0.91%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2026)
Net Profit:
-66 Million
Pharmaceuticals & Biotechnology
USD 309 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-2.86
-248.07%
20.17






